title: The ovarian remnant syndrome and ureteral obstruction: medical management.
abstract: The ovarian remnant syndrome represents the development of symptoms due to residual ovarian tissue after bilateral salpingo-oophorectomy. Treatment generally consists of surgical resection but recurrence after resection is common. A case is reported in which a postoperative recurrent ovarian remnant was successfully managed by using a luteinizing hormone-releasing hormone agonist. In addition, this report includes a survey of gynecologists to determine the frequency of this syndrome and of ureteral involvement.
authors.affiliation: Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765.
authors.forename: M O
authors.initials: MO
authors.lastname: Koch
authors.forename: D
authors.initials: D
authors.lastname: Coussens
authors.forename: L
authors.initials: L
authors.lastname: Burnett
mesh_terms: D000328:Adult; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D015994:Incidence; D016729:Leuprolide / Q000627:therapeutic use*; D010052:Ovariectomy; D010053:Ovary; D011183:Postoperative Complications / Q000188:drug therapy* / Q000453:epidemiology; D013577:Syndrome; D014517:Ureteral Obstruction / Q000188:drug therapy / Q000209:etiology*
chemical_list: D016729:Leuprolide